InvestSMART

Cochlear Limited (ASX: COH) - Announcements

Current share price for COH : $141.780 0.62 (0.44%)+

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9,272 Cochlear Completes Share Purchase Plan 28 Apr 2020 4:20PM $185.920 $141.780 fallen by 23.74%
$9,272 Cochlear receives expedited FDA approval of Remote Check 8 Apr 2020 10:20AM $182.110 $141.780 fallen by 22.15%
$9,272 Temporary pay reduction for Board, CEO & senior executives 7 Apr 2020 9:23AM $191.370 $141.780 fallen by 25.91%
$9,272 Becoming a substantial holder 2 Apr 2020 4:53PM $190.000 $141.780 fallen by 25.38%
$9,272 Cochlear Share Purchase Plan Offer Open 1 Apr 2020 9:36AM $187.450 $141.780 fallen by 24.36%
$9,272 Cleansing Notice under Section 708A(5)(e) of the Corporation 31 Mar 2020 9:38AM $182.810 $141.780 fallen by 22.44%
$9,272 Appendix 2A 30 Mar 2020 9:59AM $166.470 $141.780 fallen by 14.83%
$9,272 Appendix 3B - Update to Proposed Issue of Securities - COH 27 Mar 2020 2:29PM $170.540 $141.780 fallen by 16.86%
$9,272 Successful completion of A$880M Institutional Placement 26 Mar 2020 8:43AM $168.000 $141.780 fallen by 15.61%
$9,272 Proposed issue of Securities - COH 25 Mar 2020 9:44AM $168.000 $141.780 fallen by 15.61%
$9,272 Investor Presentation 25 Mar 2020 8:45AM $168.000 $141.780 fallen by 15.61%
$9,272 Cochlear Limited announces capital raising to enhance liquid 25 Mar 2020 8:41AM $168.000 $141.780 fallen by 15.61%
$9,272 Trading Halt 25 Mar 2020 8:19AM $168.000 $141.780 fallen by 15.61%
$9,272 Adverse appeal decision in the US patent infringement case 17 Mar 2020 9:10AM $174.510 $141.780 fallen by 18.76%
$9,272 Cochlear withdraws FY20 earnings guidance due to coronavirus 16 Mar 2020 9:51AM $216.110 $141.780 fallen by 34.39%
$9,272 Appendix 2A 12 Mar 2020 4:35PM $178.490 $141.780 fallen by 20.57%
$9,272 HY20 Result Presentation Slides 18 Feb 2020 8:37AM $234.560 $141.780 fallen by 39.55%
$9,272 HY20 Result ASX & Media Release 18 Feb 2020 8:36AM $234.560 $141.780 fallen by 39.55%
$9,272 Dividend/Distribution - COH 18 Feb 2020 8:34AM $234.560 $141.780 fallen by 39.55%
$9,272 Half Yearly Report and Accounts 18 Feb 2020 8:33AM $234.560 $141.780 fallen by 39.55%
$9,272 Cochlear announces additional investment in Nyxoah 13 Feb 2020 9:19AM $232.870 $141.780 fallen by 39.12%
$9,272 Cochlear reduces earnings guidance due to coronavirus 11 Feb 2020 9:13AM $244.760 $141.780 fallen by 42.07%
$9,272 Initial Director's Interest Notice - Appendix 3X M G Daniell 6 Jan 2020 10:17AM $223.320 $141.780 fallen by 36.51%
$9,272 Change in substantial holding 11 Dec 2019 8:31AM $227.420 $141.780 fallen by 37.66%
$9,272 Appointment of Michael Daniell to the Cochlear Limited Board 10 Dec 2019 12:02PM $229.135 $141.780 fallen by 38.12%

601 - 625 of 947 results

Page 25 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.